Assura Regulatory News (AGR)

4 March 2021

Assura plc

Notice of Dividend

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.71 pence per share will be paid on 14 April 2021 to shareholders on the register on 12 March 2021 (the "Record Date"). The Ex-dividend Date will be 11 March 2021.

This interim dividend will be wholly Property Income Distribution ("PID"). Forms to register for gross PIDs are available on the Company's website and must be returned to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL to arrive by 4.30pm on 1 April 2021. Please refer to Company's website HERE for more information.

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 18 March 2021.

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 1 April 2021 either to return their completed mandate form to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

The Circular concerning this Scrip Dividend Alternative is available on the Company's website, www.assuraplc.com and is also available for inspection at the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism. 

- Ends -

For more information, please contact:

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association